» Articles » PMID: 36670402

Screening for Cervical Cancer Among Women in Five Countries in Sub-saharan Africa: Analysis of the Role Played by Distance to Health Facility and Socio-demographic Factors

Overview
Publisher Biomed Central
Specialty Health Services
Date 2023 Jan 20
PMID 36670402
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cervical cancer significantly affects women in Sub-Saharan Africa (SSA). However, limited studies have concentrated on cervical screening behaviour among women in SSA. This study aimed to assess the interplay of distance to health facilities and socio-demographic factors with cervical screening behaviour among women in five SSA countries.

Methods: The study was based on pooled data of 40,555 women included in Demographic and Health Surveys (DHS) conducted between 2013 to 2021. Proportions and logistic regression models were used in assessing the interplay of distance to health facilities and socio-demographic factors with cervical screening behaviour.

Results: Approximately, 7.9% of women that saw the distance to a health facility as a big problem, tested for cervical cancer compared to 13.5% who indicated that distance to a health facility is not a big problem. More women in urban areas, with a higher level of education, of richest wealth index, aged 40-44 years and using contraceptives who also indicated that distance to a health facility was a big problem tested for cervical cancer compared to those in rural areas with no education, of poorest wealth index, aged 15-19 years and not using contraceptives. Education, age, contraceptive use, frequent exposure to mass media and Sexual Transmitted Infections (STI) had a significant relationship with testing for cervical cancer.

Conclusion: The prevalence of cervical cancer screening was low in the five SSA countries largely due to distance barriers and was also significantly influenced by education, age, contraceptive use, frequent exposure to mass media, and STI status. To improve the screening for cervical cancer and its associated benefits in the five SSA countries, there is a need for policymakers, clinicians and public health workers to channel more commitment and efforts to addressing the barriers identified in this study.

Citing Articles

Cervical cancer screening uptake and its predictors among women aged 30-49 in Ghana: Providing evidence to support the World Health Organization's cervical cancer elimination initiative.

Adzigbli L, Aboagye R, Adeleye K, Osborne A, Ahinkorah B BMC Infect Dis. 2025; 25(1):246.

PMID: 39984848 PMC: 11843744. DOI: 10.1186/s12879-025-10485-6.


Multiple sexual partnership as an independent predictor of cervical cancer screening among women of reproductive age: an analysis of the 2022 Kenya demographic and health survey.

Okyere J BMC Cancer. 2025; 25(1):259.

PMID: 39953452 PMC: 11827377. DOI: 10.1186/s12885-025-13704-0.


Factors Influencing Cervical Cancer Screening: A Cross-Sectional Study Among Ethnically Diverse Women in the Kumasi Metropolis of Ghana.

Abubakari A, Gross J, Kwaku I, Boateng I Health Sci Rep. 2025; 8(2):e70433.

PMID: 39949523 PMC: 11821460. DOI: 10.1002/hsr2.70433.


Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey.

Anaba E, Alor S, Badzi C, Mbuwir C, Muki B, Afaya A BMC Cancer. 2024; 24(1):920.

PMID: 39080553 PMC: 11290011. DOI: 10.1186/s12885-024-12697-6.


Knowledge and attitude toward cervical cancer screening among women aged 30-49 years attending selected health facilities in Ethiopia: Using structural equation model.

Nimani T, Bayisa F, Debebe Jimma S, Assefa A Heliyon. 2024; 10(10):e31596.

PMID: 38831821 PMC: 11145502. DOI: 10.1016/j.heliyon.2024.e31596.


References
1.
Klein C, Kahesa C, Mwaiselage J, West J, Wood C, Angeletti P . How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa. Front Cell Infect Microbiol. 2020; 10:23. PMC: 7028704. DOI: 10.3389/fcimb.2020.00023. View

2.
Stewart T, Moodley J, Walter F . Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa. Cancer Epidemiol. 2018; 53:81-92. DOI: 10.1016/j.canep.2018.01.014. View

3.
Ba D, Ssentongo P, Musa J, Agbese E, Diakite B, Traore C . Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study. Cancer Epidemiol. 2021; 72:101930. PMC: 8864323. DOI: 10.1016/j.canep.2021.101930. View

4.
Bosch F, Burchell A, Schiffman M, Giuliano A, de Sanjose S, Bruni L . Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008; 26 Suppl 10:K1-16. DOI: 10.1016/j.vaccine.2008.05.064. View

5.
Giannella L, Rossi P, Delli Carpini G, Di Giuseppe J, Bogani G, Gardella B . Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3. Gynecol Oncol. 2021; 161(3):741-747. DOI: 10.1016/j.ygyno.2021.03.025. View